The cyclic GMP-dependent protein kinase Iα suppresses kidney fibrosis

Kidney International

Volumn 84, Issue 6, 2013, Pages 1198-1206

  Schinner, Elisabeth ^a   Schramm, Andrea ^a   Kees, Frieder ^a   Hofmann, Franz ^b   Schlossmann, Jens ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

cGMP; cGMP dependent protein kinase; interstitial fibrosis; nitric oxide

Indexed keywords

CALVASCULIN; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; FIBRONECTIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYCLIC GMP DEPENDENT PROTEIN KINASE 1 GENE; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; COLLAGEN TYPE I; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE I; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME ACTIVATORS; FIBROBLASTS; FIBRONECTINS; FIBROSIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANYLATE CYCLASE; ISOENZYMES; KIDNEY; KIDNEY DISEASES; MICE; MICE, 129 STRAIN; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; RNA, MESSENGER; S100 PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; URETERAL OBSTRUCTION;

EID: 84888643072     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.219     Document Type: Article

References (42)

1. Hofmann F, Bernhard D, Lukowski R et al. cGMP regulated protein kinases (cGK). Handb Exp Pharmacol 2009; 191: 137-162.
2. Weber S, Bernhard D, Lukowski R et al. Rescue of cGMP kinase I knockout mice by smooth muscle specific expression of either isozyme. Circ Res 2007; 101: 1096-1103.
3. Geiselhoringer A, Gaisa M, Hofmann F et al. Distribution of IRAG and cGKI-isoforms in murine tissues. FEBS Lett 2004; 575: 19-22.
4. Joyce NC, DeCamilli P, Lohmann SM et al. cGMP-dependent protein kinase is present in high concentrations in contractile cells of the kidney vasculature. J Cyclic Nucleotide Protein Phosphor Res 1986; 11: 191-198.
5. Gambaryan S, Hausler C, Markert T et al. Expression of type II cGMPdependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression. J Clin Invest 1996; 98: 662-670.
6. Wagner C, Pfeifer A, Ruth P et al. Role of cGMP-kinase II in the control of renin secretion and renin expression. J Clin Invest 1998; 102: 1576-1582.
7. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
8. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508.
9. el Nahas AM. Renal scarring: A multi-organ approach to fibrosis. Exp Nephrol 1995; 3: 69-70.
10. Nasreen N, Mohammed KA, Mubarak KK et al. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol 2009; 297: L115-L124.
11. Tang WW, Ulich TR, Lacey DL et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996; 148: 1169-1180.
12. Desmouliere A, Geinoz A, Gabbiani F et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103-111.
13. Alvarez RJ, Sun MJ, Haverty TP et al. Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 1992; 41: 14-23.
14. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
15. Cutroneo KR. TGF-beta-induced fibrosis and SMAD signaling: Oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen 2007; 15(Suppl 1): S54-S60.
16. Roberts AB, McCune BK, Sporn MB. TGF-beta: Regulation of extracellular matrix. Kidney Int 1992; 41: 557-559.
17. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000; 14: 627-644.
18. Schnaper HW, Hayashida T, Poncelet AC. It's a Smad world: Regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol 2002; 13: 1126-1128.
19. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968.
20. Das S, Au E, Krazit ST et al. Targeted disruption of guanylyl cyclase-A/
21. natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice: Role of proinflammatory cytokines. Endocrinology 2010; 151: 5841-5850.
22. Sawada N, Itoh H, Miyashita K et al. Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- And antifibrotic signals in blood vessels. Mol Cell Biol 2009; 29: 6018-6032.
23. Geschka S, Kretschmer A, Sharkovska Y et al. Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats. PLoS ONE 2011; 6: E21853.
24. Nishikimi T, Inaba-Iemura C, Ishimura K et al. Natriuretic peptide/
25. natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. Regul Pept 2009; 154: 44-53.
26. Wentworth JK, Pula G, Poole AW. Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets. Biochem J 2006; 393: 555-564.
27. Butt E. cGMP-dependent protein kinase modulators. Handb Exp Pharmacol 2009; 191: 409-421.
28. Peters H, Wang Y, Loof T et al. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis. Kidney Int 2004; 66: 2224-2236.
29. Qiu P, Feng XH, Li L. Interaction of Smad3 and SRF-Associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation. J Mol Cell Cardiol 2003; 35: 1407-1420.
30. Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens 2008; 17: 266-270.
31. Weinstein JR, Anderson S. The aging kidney: Physiological changes. Adv Chronic Kidney Dis 2010; 17: 302-307.
32. Rothermund L, Friebe A, Paul M et al. Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats. Br J Pharmacol 2000; 130: 205-208.
33. Willis BC, Borok Z. TGF-beta-induced EMT: Mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293: L525-L534.
34. Schwappacher R, Weiske J, Heining E et al. Novel crosstalk to BMP signalling: CGMP-dependent kinase I modulates BMP receptor and Smad activity. Embo J 2009; 28: 1537-1550.
35. Peng F, Zhang B, Wu D et al. TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae. Am J Physiol Renal Physiol 2008; 295: F153-F164.
36. Huang X, Gai Y, Yang N et al. Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am J Pathol 2011; 179: 2751-2765.
37. Tomasek JJ, Gabbiani G, Hinz B et al. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-363.
38. Kato M, Blanton R, Wang GR et al. Direct binding and regulation of RhoA by cyclic GMP-dependent protein kinase Ialpha. J Biol Chem 2012; 287: 41342-41351.
39. Antl M, von Bruhl ML, Eiglsperger C et al. IRAG mediates NO/cGMPdependent inhibition of platelet aggregation and thrombus formation. Blood 2007; 109: 552-559.
40. Niedermeier M, Reich B, Rodriguez Gomez M et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009; 106: 17892-17897.
41. Lopez-De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985; 33: 737-743.
42. Dunn SR, Qi Z, Bottinger EP et al. Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int 2004; 65: 1959-1967.